Background Image
Previous Page  27 / 50 Next Page
Information
Show Menu
Previous Page 27 / 50 Next Page
Page Background

WHY IS IN OUR DNA.

Imaging plays a pivotal role in the

delivery of Personalized Cancer

Medicine. It is a core component of:

• early cancer detection

• surgical and radiation treatment

planning

• monitoring treatment response

• surveillance of patients

for recurrence

Getting a clear picture

of cancer

S

usan Armitage’s life has certainly

been impacted by cancer, starting

back in 2001 when she lost her

husband Murray to cancer. Then, in 2012,

Susan herself was diagnosed with chronic

lymphocytic leukemia (CLL) which she

continues to be monitored for today.

MRI machines—which provide high

quality medical images—are required to

prepare for and monitor the treatment of

cancer patients. However, they are very

problematic for people with claustrophobia

like Susan. In fact, approximately five

percent of the population experiences

claustrophobia to some degree.

When Susan was contemplating a

donation to Princess Margaret Cancer

Centre, she wanted her donation to help

others affected by claustrophobia, but

she wanted it to have a broader benefit

as well. Almost all cancer patients require

imaging at some point in their diagnosis

or treatment, so she decided to direct her

gift of $1 million towards the purchase of

a very sophisticated MR imaging machine

that features newer short bore (tunnel) and

wide-opening design to make it easier for

patients who are claustrophobic.

I

n addition to overseeing imaging

procedures and the interpretation

of results, the radiologists at

Princess Margaret Cancer Centre

now have access to (and are

developing themselves) cutting

edge technology that enables them

to deliver new treatment protocols

that are life-saving alternatives for

patients who do not qualify for

surgery. Recently, radiofrequency

ablation and thermal ablation

techniques have been used

successfully for several types of

cancer and are being evaluated

through our clinical trials program.